These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15347305)

  • 21. Resistance rate to antibiotics of Helicobacter pylori isolates in eastern Taiwan.
    Hu CT; Wu CC; Lin CY; Cheng CC; Su SC; Tseng YH; Lin NT
    J Gastroenterol Hepatol; 2007 May; 22(5):720-3. PubMed ID: 17444862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary and secondary treatment for Helicobacter pylori in the United States.
    Vakil N
    Rev Gastroenterol Disord; 2005; 5(2):67-72. PubMed ID: 15976737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Sensitivity and resistance of Helicobacter pylori to antibiotic treatment].
    Avidan B; Weiss B; Chowers Y; Younash A; Bar-Meir S; Keler N
    Harefuah; 1999 Oct; 137(7-8):272-4, 352, 351. PubMed ID: 12415967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori.
    Fischbach L; Evans EL
    Aliment Pharmacol Ther; 2007 Aug; 26(3):343-57. PubMed ID: 17635369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antibiotic resistance of Helicobacter pylori].
    Wang F; Shen SR; Zhou JD; Xu CX
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 32(3):447-50. PubMed ID: 17611323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Helicobacter pylori treatment: is sequential or quadruple therapy the answer?
    Vakil N
    Rev Gastroenterol Disord; 2008; 8(2):77-82. PubMed ID: 18641590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of Helicobacter pylori infection.
    Egan BJ; Marzio L; O'Connor H; O'Morain C
    Helicobacter; 2008 Oct; 13 Suppl 1():35-40. PubMed ID: 18783520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Helicobacter pylori Treatment Failure: The Rationale for Alternative Antibiotics.
    O''Morain C; Smith S
    Digestion; 2016; 93(4):309-10. PubMed ID: 27246467
    [No Abstract]   [Full Text] [Related]  

  • 29. Helicobacter pylori infection in pediatrics.
    Veres G; Pehlivanoglu E
    Helicobacter; 2007 Oct; 12 Suppl 1():38-44. PubMed ID: 17727459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Annual change of primary resistance to clarithromycin among Helicobacter pylori isolates from 1996 through 2008 in Japan.
    Horiki N; Omata F; Uemura M; Suzuki S; Ishii N; Iizuka Y; Fukuda K; Fujita Y; Katsurahara M; Ito T; Cesar GE; Imoto I; Takei Y
    Helicobacter; 2009 Oct; 14(5):86-90. PubMed ID: 19751432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial susceptibility of Helicobacter pylori isolates of dyspeptic Nigerian patients.
    Abdulrasheed A; Lawal OO; Abioye-Kuteyi EA; Lamikanra A
    Trop Gastroenterol; 2005; 26(2):85-8. PubMed ID: 16225052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cure of Helicobacter pylori infection in all compliant patients: report on 644 subjects.
    Seppälä K; Kosunen TU; Veijola L; Sipponen P; Arkkila PE; Rautelin H; Tilvis R
    Scand J Gastroenterol; 2008; 43(9):1149-50. PubMed ID: 18609180
    [No Abstract]   [Full Text] [Related]  

  • 33. A community-based study of Helicobacter pylori therapy using the strategy of test, treat, retest, and re-treat initial treatment failures.
    Lee YC; Wu HM; Chen TH; Liu TY; Chiu HM; Chang CC; Wang HP; Wu MS; Chiang H; Wu MC; Lin JT
    Helicobacter; 2006 Oct; 11(5):418-24. PubMed ID: 16961802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of Helicobacter pylori.
    Wolle K; Malfertheiner P
    Best Pract Res Clin Gastroenterol; 2007; 21(2):315-24. PubMed ID: 17382279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meta-analysis: Lactobacillus containing quadruple therapy versus standard triple first-line therapy for Helicobacter pylori eradication.
    Zou J; Dong J; Yu X
    Helicobacter; 2009 Oct; 14(5):97-107. PubMed ID: 19751434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Helicobacter pylori infection in children: management and pharmacotherapy.
    Sabbi T; De Angelis P; Dall'Oglio L
    Expert Opin Pharmacother; 2008 Mar; 9(4):577-85. PubMed ID: 18312159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Recent topics on important drugs for H. pylori eradication: Amoxicillin (AMPC)].
    Hiramatsu K; Nasu M
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():367-71. PubMed ID: 16363561
    [No Abstract]   [Full Text] [Related]  

  • 38. Antimicrobial resistance in Helicobacter pylori: current situation and management strategy in Vietnam.
    Phan TN; Tran VH; Tran TN; Le VA; Santona A; Rubino S; Paglietti B
    J Infect Dev Ctries; 2015 Jul; 9(6):609-13. PubMed ID: 26142670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of metronidazole as second-line drug for the treatment of Helicobacter pylori Infection in the Japanese population: a multicenter study in the Tokyo Metropolitan Area.
    Matsuhisa T; Kawai T; Masaoka T; Suzuki H; Ito M; Kawamura Y; Tokunaga K; Suzuki M; Mine T; Takahashi S; Sakaki N
    Helicobacter; 2006 Jun; 11(3):152-8. PubMed ID: 16684262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pylera for the eradication of Helicobacter pylori infection.
    Saleem A; Qasim A; O'Connor HJ; O'Morain CA
    Expert Rev Anti Infect Ther; 2009 Sep; 7(7):793-9. PubMed ID: 19735221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.